4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-24-009543
Chief Scientific Officer gave up 2,709 shares (to pay taxes)
- Chief Scientific Officer acquired 5,860 shares (grant or award)
- Chief Scientific Officer acquired 9,275 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-30 | Exercise or conversion : show line 1 in the form | +9,275 | 29,699 | D | ||
| 2024-01-30 | Shares withheld for taxes : show line 2 in the form | −2,709 | $9.80 | $26,548 | 26,990 | D |
| 2024-01-31 | Grant or award : show line 3 in the form | +5,860 | $2.69 | $15,763 | 32,850 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-30 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −9,275 | 27,825 | D |
Loading xslF345X05/tm244961-5_4seq1.xml…